Selected Grants
Drug Development of Skp2 PROTACs in Cancer (1 R01 CA277682-01)
ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2023 - 2028Identification of a novel targetable cancer stem cell regulator promoting cancer progression and metastasis in non-small cell lung cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2028Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2027Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2026External Relationships
- 2023 Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine, Taiwan
- Academia Sinica, Taiwan
- Chang Gung University of Science and Technology
- Chang Gung University, Taiwan
- Institute of Biomedical Sciences at Academia Sinica, Taiwan
- Kaohsiung Medical University
- National Health Research Institute, Taiwan
- National Science and Technology Council, Taiwan
- National Yang Ming Chiao Tong University, Taiwan
- Seventy Anniversary of NTU Pharmacy Annual Conference, Taiwan
- Stablix, Inc
- Taipei Medical University
- The 37th Joint Annual Conference of Biomedical Science (JACBS)Annual Conference of Biomedical Science (JACBS)
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.